GR3024028T3 - Cytotoxic and antiviral compound. - Google Patents

Cytotoxic and antiviral compound.

Info

Publication number
GR3024028T3
GR3024028T3 GR970401683T GR970401683T GR3024028T3 GR 3024028 T3 GR3024028 T3 GR 3024028T3 GR 970401683 T GR970401683 T GR 970401683T GR 970401683 T GR970401683 T GR 970401683T GR 3024028 T3 GR3024028 T3 GR 3024028T3
Authority
GR
Greece
Prior art keywords
cytotoxic
antiviral compound
compound
kalahide
sacoglossan
Prior art date
Application number
GR970401683T
Other languages
English (en)
Inventor
Paul J Schauer
Mark T Hamann
Dolores G Gravalos
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of GR3024028T3 publication Critical patent/GR3024028T3/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
GR970401683T 1993-02-03 1997-07-09 Cytotoxic and antiviral compound. GR3024028T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939302046A GB9302046D0 (en) 1993-02-03 1993-02-03 Antiumoral compound-v

Publications (1)

Publication Number Publication Date
GR3024028T3 true GR3024028T3 (en) 1997-10-31

Family

ID=10729727

Family Applications (1)

Application Number Title Priority Date Filing Date
GR970401683T GR3024028T3 (en) 1993-02-03 1997-07-09 Cytotoxic and antiviral compound.

Country Status (11)

Country Link
EP (1) EP0610078B1 (el)
JP (1) JP3452628B2 (el)
AT (1) ATE151776T1 (el)
AU (1) AU677258B2 (el)
CA (1) CA2114859C (el)
DE (1) DE69402576T2 (el)
DK (1) DK0610078T3 (el)
ES (1) ES2102772T3 (el)
GB (1) GB9302046D0 (el)
GR (1) GR3024028T3 (el)
ZA (1) ZA94748B (el)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0002952D0 (en) * 2000-02-09 2000-03-29 Pharma Mar Sa Process for producing kahalalide F compounds
HUP0600031A3 (en) 2000-10-31 2012-02-28 Pharma Mar Kahalalide formulations and their use
EP1435990A1 (en) * 2001-10-19 2004-07-14 Pharma Mar, S.A. Kahalalide compounds for use in cancer therapy
JP4430009B2 (ja) * 2002-10-18 2010-03-10 ファーマ・マール・エス・アー・ウー 新規な抗腫瘍化合物
KR101149095B1 (ko) * 2002-10-18 2012-05-30 파르마 마르 에스.에이.유. 4-메틸헥사노 카할라리드 ｆ 화합물
GB0304367D0 (en) * 2003-02-26 2003-04-02 Pharma Mar Sau Methods for treating psoriasis
US7507708B2 (en) 2003-02-26 2009-03-24 Pharma Mar, S.A.U. Antitumoral compounds
GB0321066D0 (en) 2003-09-09 2003-10-08 Pharma Mar Sau New antitumoral compounds
WO2009052379A2 (en) * 2007-10-19 2009-04-23 Pharma Mar, S.A. Improved antitumoral treatments
MX2010009782A (es) * 2008-03-07 2010-09-30 Pharma Mar Sa Tratamientos antitumorales mejorados.
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE83480T1 (de) * 1988-09-05 1993-01-15 Sankyo Co Cyclisches peptid, seine herstellung und seine verwendung zur behandlung von cardiovasculaeren stoerungen.
US4986988A (en) * 1989-05-18 1991-01-22 Arizona Board Of Regents Isolation and structural elucidation of the cytostatic linear depsipeptides dolastatin 13 and dehydrodolastatin 13

Also Published As

Publication number Publication date
DE69402576D1 (de) 1997-05-22
DK0610078T3 (da) 1997-10-20
ES2102772T3 (es) 1997-08-01
AU5491194A (en) 1994-08-11
ATE151776T1 (de) 1997-05-15
JPH0770185A (ja) 1995-03-14
DE69402576T2 (de) 1997-10-02
ZA94748B (en) 1994-09-29
GB9302046D0 (en) 1993-03-24
JP3452628B2 (ja) 2003-09-29
EP0610078B1 (en) 1997-04-16
CA2114859A1 (en) 1994-08-04
EP0610078A1 (en) 1994-08-10
CA2114859C (en) 2008-04-15
AU677258B2 (en) 1997-04-17

Similar Documents

Publication Publication Date Title
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
IL94915A0 (en) Substituted quinazolinones and pharmaceutical compositions containing them
PL304649A1 (en) Novel derivatives of taxane and pharmaceutical agents
HUT59109A (en) Process for producing hydroxymethyl-(methylenecyclopentyl)-purines and -pyrimidines, their pharmaceutically acceptable salts and pharmaceutical compositions comprising same
IN172553B (el)
KR0156747B1 (en) Use of 1,3-oxathiolan nucleoside analogues in the treatment of hepatitis-b
TW289020B (el)
TW226375B (el)
AU4755393A (en) Azaquinoxalines, processes for their preparation and their use
HU9302335D0 (en) 9-|(substituted glycyl)-amido¨-6-desmethyl-6-desoxy-tetracyclines
IL94484A0 (en) Diarylstyrylquinoline diacids and pharmaceutical compositions containing them
CA2075173A1 (en) Compounds and methods for inhibition of hiv and related viruses
AU1485392A (en) Quinoxalines, processes for their preparation, and their use
NZ226845A (en) 2', 3'-dideoxy-2'-fluoronucleosides; pharmaceutical compositions and processes for their preparation
TW280813B (el)
ZA94748B (en) Cytotoxic and antiviral compound.
CA2152771A1 (en) 7-o-ethers of taxane derivatives
ZA955793B (en) Benzothiadiazine compound process for its preparation and the pharmaceutical compositions which contain it
HUT66234A (en) Process to prepare 4,13-dioxabicyclo(8.2.1)-tridecenon-derivatives and pharmaceutical compositions containing them
IL110460A0 (en) Bis-naphthalimides and pharmaceutical compositions containing them
MY132057A (en) Quinoxalinones, a process for their preparation and their use
IL109866A0 (en) Crystalline 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (+) l-hydrogentartrate, its preparation and pharmaceutical compositions containing it
EP0855398A4 (en) SESQUITERPEN DERIVATIVES WITH ANTIVITAL ACTIVITY
AU4706489A (en) Oxadiazol-azabicycl compounds and their pharmaceutical use
EP0412941A3 (en) Phospholipids for the treatment of multiple sclerosis